- Reports
- Lisa Graves
- Mary Bottari
- Wendell Potter
- Brendan Fischer
- Rebekah Wilce
- Sara Jerving
- Harriet Rowan
- Jonathan Rosenblum
- Will Dooling
- Emily Osborne
- Abdul Raziq
- Guest Contributor
- Archives
- Alex Carlin
- Anne Landman
- Bob Burton
- Chelsea Lawliss
- Diane Farsetta
- Eric Carlson
- Jennifer Page
- Jessica Opoien
- Jill Richardson
- John Stauber
- Judith Siers-Poisson
- Maxwell Abbott
- Megha Desai
- Monica Chang
- Osasumwen Izevbigie
- Patrick Moran
- Rebecca Sandler
- Ross Wolfarth
- Sarah Olson
- Sheldon Rampton
- Steve Horn
- Take Action
- Latest News
- Media
- SourceWatch
- Publications
- About Us
- Why Donate?
Thanks to the Plastics Industry, Big Tobacco's Lobbying Tactics Stay Fresher, Last Longer
The plastics industry has launched a $10 million PR blitz aimed at stopping the U.S. Food and Drug Administration (FDA) from re-evaluating its declaration that a widely-used plastics additive called Bisphenol A (BPA) is safe. The Society for the Plastics Industry, a trade and lobbying group for companies that manufacture products containing BPA, is using many of the same PR strategies, and even the same PR companies, that the tobacco industry used in its decades-long fight against regulation. To discourage reconsideration of the health hazards of BPA, the plastics industry is downplaying the risks of the additive, discrediting anyone who portrays the chemical as a health threat, and utilizing Web 2.0 technology, like blogs, Facebook, Twitter, Wikipedia and YouTube, to plant "Trojan Horse" messages. The plastics industry is also using the lobbying and PR firms Apco Worldwide and the Weinberg Group, both of which worked closely with the tobacco industry to help confuse the public about the health hazards of secondhand smoke. The Milwaukee Journal-Sentinel uncovered tobacco industry documents that show the overlap between the two industries. The tobacco industry was concerned about the BPA issue because cigarette filters and package wrapping contain the additive. The documents also show that FDA scientists tapped chemical industry lobbyists for help drafting public safety standards on BPA.




